yamamoto

  1. F

    Lipopolysaccharide shock reveals immune function of indoleamine 2,3-dioxygenase 2 through regulation of IL-6/stat3 signalling, 2018, Yamamoto et al

    Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling [https://www.nature.com/articles/s41598-018-34166-4]
  2. Sly Saint

    BIOMARKER FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) - Yamamoto et al 27 Feb 2020

    https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020040210&tab=PCTBIBLIO (main paper in japanese)
Back
Top Bottom